Champions Oncology, Inc. logo

Champions Oncology, Inc.

US-based, End-to-End Oncology Pharmacology Solutions CRO

183 employees · est. 2007 · Hackensack, United States

VS
Repositive - no longer trading logo

Repositive - no longer trading

Accelerating biomedical research by connecting biopharmas with the right preclinical cancer models and CRO partners

1 employees · est. 2014 · Cambridge, United Kingdom

Champions Oncology, Inc. is the older company (2007 vs 2014); Champions Oncology, Inc. is the larger of the two.

Side-by-Side Comparison

Champions Oncology, Inc. Repositive - no longer trading
Founded
2007 older 2014
Headquarters
Hackensack, United States Cambridge, United Kingdom
Employees
183 larger 1
Industry
Biotechnology, Health Care Analytics, Big Data, Data Analytics
Funding Stage
IPO Series A
Total Funding
$36.80M $3.30M
Funding Rounds
6 6
Services
Preclinical and Clinical Specialty Testing, Oncology Research Solutions, Data Ecosystem with Multi-Omic Dataset, Custom Flow Cytometry Development, Radiopharmaceutical Testing Not tracked yet
Target Customers
Biotech Companies, Pharmaceutical Companies, Oncology Researchers, Drug Development Teams Not tracked yet
Taxonomy
Oncology Pharmacology, CRO, Oncology Research, TumorGraft, PDX Models, Clinical Collaboration Network, Personalized Oncology Solutions, Genome Sequencing, Translational Oncology Research, Patient Derived Xenograft, Immuno-Oncology, Flow Cytometry, Syngeneic Models, Humanized Mouse Models, GCP Biomedical Research, Precision Cancer Therapies, Preclinical Cancer Models, Contract Research Organisations, Oncology Projects, AI In Drug Discovery, Genomic Data Sharing, Biotech, Pharma, Translational Oncology
Website
championsoncology.com repositive.io
Champions Oncology, Inc. logo

About Champions Oncology, Inc.

Champions Oncology, Inc., established in 2007, is a US-based biotech firm specializing in oncology-focused Contract Research Organization (CRO) services. The company's tagline, "US-based, End-to-End Oncology Pharmacology Solutions CRO", underscores its comprehensive suite of offerings that enhance t...

Repositive - no longer trading logo

About Repositive - no longer trading

Repositive is a United Kingdom-based startup committed to expediting the development of precision cancer therapies by collaborating with biopharmas and Contract Research Organisations (CROs). Founded in 2014, the company's slogan "Accelerating biomedical research by connecting biopharmas with the ri...

We will tell you when either one moves

BounceWatch watches Champions Oncology, Inc. and Repositive - no longer trading for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Champions Oncology, In... and Repositive - no longer... — by email.

Frequently Asked Questions

Champions Oncology, Inc. — US-based, End-to-End Oncology Pharmacology Solutions CRO. Repositive - no longer trading — Accelerating biomedical research by connecting biopharmas with the right preclinical cancer models and CRO partners. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Champions Oncology, Inc. has raised $36.80M while Repositive - no longer trading has raised $3.30M.
Champions Oncology, Inc. and Repositive - no longer trading operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Champions Oncology, Inc. with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Champions Oncology, Inc. on 11 Sep 2024, and Repositive - no longer trading on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes